宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01541 宜明昂科-B

已收盘 07-16 16:08:05

9.790

-0.210

-2.10%

最高10.520	最低9.790	成交量465.26万
今开10.060	昨收10.000	日振幅7.30%
总市值39.88亿	流通市值38.80亿	总股本4.07亿
成交额4,724万	换手率1.17%	流通股本3.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":9.79,"timestamp":1752653285657,"preClose":10,"halted":0,"volume":4652600,"delay":0,"floatShares":396277305,"shares":407307695,"eps":-0.9147520250178586,"marketStatus":"已收盘","change":-0.21,"latestTime":"07-16 16:08:05","open":10.06,"high":10.52,"low":9.79,"amount":47241126,"amplitude":0.073,"askPrice":9.8,"askSize":50000,"bidPrice":9.79,"bidSize":9000,"shortable":0,"etf":0,"ttmEps":-0.9147520250178586,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":5,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":10,"openAndCloseTimeList":[[1752629400000,1752638400000],[1752642000000,1752652800000]],"volumeRatio":1.240773,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01541","defaultTab":"news","newsList":[{"id":"2551577441","title":"宜明昂科-B07月15日主力净流入850.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2551577441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551577441?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:15","pubTimestamp":1752567340,"startTime":"0","endTime":"0","summary":"07月15日, 宜明昂科-B股价涨0.40%，报收10.00元，成交金额3207.6万元，换手率0.80%，振幅6.53%，量比0.88。宜明昂科-B今日主力资金净流入850.1万元，上一交易日主力净流出159.7万元。该股近5个交易日下跌14.34%，主力资金累计净流入338.3万元；近20日主力资金累计净流出4418.5万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165325a44be877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165325a44be877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2551920784","title":"宜明昂科-B盘中异动 早盘大幅下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551920784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551920784?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:24","pubTimestamp":1752459882,"startTime":"0","endTime":"0","summary":"2025年07月14日早盘10时24分，宜明昂科-B股票出现异动，股价急速下跌5.10%。截至发稿，该股报9.680港元/股，成交量90.82万股，换手率0.23%，振幅5.49%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。宜明昂科-B股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，北海康成-B、创胜集团-B、博安生物涨幅较大，振幅较大的相关个股有北海康成-B、创胜集团-B、博安生物，振幅分别为24.32%、15.24%、11.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410244295417c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410244295417c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2550069036","title":"宜明昂科-B盘中异动 股价大跌5.04%报10.920港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550069036?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:52","pubTimestamp":1752198758,"startTime":"0","endTime":"0","summary":"2025年07月11日早盘09时52分，宜明昂科-B股票出现异动，股价大幅跳水5.04%。截至发稿，该股报10.920港元/股，成交量30.98万股，换手率0.08%，振幅4.35%。资金方面，该股资金流入81.2524万港元，流出248.26万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，昭衍新药、药明合联、药明康德涨幅较大，振幅较大的相关个股有昭衍新药、药明合联、药明巨诺-B，振幅分别为11.69%、8.00%、7.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711095238a4439ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711095238a4439ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2550827416","title":"宜明昂科-B07月09日主力净流出7.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550827416","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550827416?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:15","pubTimestamp":1752048940,"startTime":"0","endTime":"0","summary":"07月09日, 宜明昂科-B股价跌3.63%，报收11.16元，成交金额2247.4万元，换手率0.50%，振幅4.66%，量比0.53。宜明昂科-B今日主力资金净流出7.4万元，上一交易日主力净流入42.8万元。该股近5个交易日下跌6.21%，主力资金累计净流出526.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5809.5万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165930a69f0874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165930a69f0874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2549303380","title":"宜明昂科-B盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549303380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549303380?lang=zh_cn&edition=full","pubTime":"2025-07-07 09:43","pubTimestamp":1751852611,"startTime":"0","endTime":"0","summary":"2025年07月07日早盘09时43分，宜明昂科-B股票出现波动，股价快速下挫5.21%。截至发稿，该股报12.000港元/股，成交量40.92万股，换手率0.10%，振幅5.06%。资金方面，该股资金流入145.855万港元，流出337.024万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.47%。宜明昂科-B公司简介：宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094331a43ab280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707094331a43ab280&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548355554","title":"宜明昂科-B涨4% IMM2510获FDA批准IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548355554","media":"DoNews","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548355554?lang=zh_cn&edition=full","pubTime":"2025-07-04 12:01","pubTimestamp":1751601662,"startTime":"0","endTime":"0","summary":"北京时间2025年7月4日，宜明昂科-B（01541）午前股价上涨4.27%，报12.70港元。公司与Instil联合宣布，IMM2510/AXN-2510已获美国FDA批准新药临床试验（IND）申请。该药物将用于治疗复发性/难治性实体肿瘤患者，并计划于2025年底前启动1b/2期试验，评估其安全性、疗效及药代动力学。同时，IMM2510/AXN-2510联合化疗治疗非小细胞肺癌的2期研究数据预计将于2025年下半年公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070412034295360461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070412034295360461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548334972","title":"港股异动 | 宜明昂科-B(01541)逆市涨超7% IMM2510/AXN-2510获FDA批准IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548334972","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548334972?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:35","pubTimestamp":1751592948,"startTime":"0","endTime":"0","summary":"消息面上，宜明昂科-B发布公告，本公司与Instil共同欣然宣布，Instil已自美国食品药品监督管理局取得 IMM2510/AXN-2510的新药临床试验批准。Instil预计将在2025年底前启动IMM2510/AXN-2510作为单药治疗复发性/难治性实体肿瘤患者的1b/2期试验。该试验旨在评估IMM2510/AXN-2510在实体肿瘤患者中的安全性、疗效、药物代谢动力学及药效学。此外，正在中国进行的IMM2510/AXN-2510联合化疗治疗一线非小细胞肺癌的2期研究数据预计将于2025年下半年由本公司公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 宜明昂科-B(01541)逆市涨超7% IMM2510/AXN-2510获FDA批准IND申请","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548808846","title":"宜明昂科-B07月03日获主力加仓120.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548808846","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548808846?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530540,"startTime":"0","endTime":"0","summary":"07月03日, 宜明昂科-B股价涨2.18%，报收12.18元，成交金额2918.1万元，换手率0.61%，振幅6.04%，量比0.43。宜明昂科-B今日主力资金净流入120.4万元，连续3日净流入，上一交易日主力净流入2.6万元。该股近5个交易日下跌8.56%，主力资金累计净流出3042.5万元；近20日主力资金累计净流出4433.0万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170404a72c5f2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170404a72c5f2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548893877","title":"宜明昂科-B(01541)：IMM2510/AXN-2510获美国FDA批准IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2548893877","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548893877?lang=zh_cn&edition=full","pubTime":"2025-07-02 18:06","pubTimestamp":1751450815,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，本公司与Instil共同欣然宣布，Instil已自美国食品药品监督管理局(FDA)取得 IMM2510/AXN-2510的新药临床试验(IND)批准。Instil预计将在2025年底前启动 IMM2510/AXN-2510作为单药治疗复发性/难治性实体肿瘤患者的1b/2期试验。该试验旨在评估IMM2510/AXN-2510在实体肿瘤患者中的安全性、疗效、药物代谢动力学及药效学。此外，正在中国进行的IMM2510/AXN-2510联合化疗治疗一线非小细胞肺癌(NSCLC)的2期研究数据预计将于2025年下半年由本公司公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2548830230","title":"宜明昂科-B盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548830230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548830230?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:32","pubTimestamp":1751419956,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘09时32分，宜明昂科-B股票出现异动，股价急速拉升5.00%。截至发稿，该股报12.600港元/股，成交量46.1万股，换手率0.12%，振幅5.83%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209323697969f93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209323697969f93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2547863013","title":"宜明昂科-B(01541)：付大伟及Kendall Arthur Smith获委任为提名委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2547863013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547863013?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:48","pubTimestamp":1751294898,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，非执行董事付大伟女士及独立非执行董事 Kendall Arthur Smith博士均获委任为董事会提名委员会成员，两者均自2025年6月30日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2547805840","title":"宜明昂科-B盘中异动 股价大涨5.42%报11.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547805840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547805840?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:17","pubTimestamp":1751253438,"startTime":"0","endTime":"0","summary":"2025年06月30日早盘11时17分，宜明昂科-B股票出现异动，股价急速拉升5.42%。截至发稿，该股报11.660港元/股，成交量105.1万股，换手率0.27%，振幅6.87%。资金方面，该股资金流入597.012万港元，流出497.124万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，昭衍新药、中国抗体-B、巨子生物涨幅较大，振幅较大的相关个股有昭衍新药、北海康成-B、欧康维视生物-B，振幅分别为15.54%、10.71%、9.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063011171897941082&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063011171897941082&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2546198007","title":"宜明昂科-B06月27日遭主力抛售1131.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546198007","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546198007?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:15","pubTimestamp":1751012134,"startTime":"0","endTime":"0","summary":"06月27日, 宜明昂科-B股价跌6.27%，报收11.06元，成交金额1.1亿元，换手率2.43%，振幅11.36%，量比2.58。宜明昂科-B今日主力资金净流出1131.5万元，连续3日净流出，上一交易日主力净流出2043.4万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为35.71%，平均跌幅为5.16%。该股近5个交易日下跌12.22%，主力资金累计净流出3374.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4840.5万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172651a4c0dd11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172651a4c0dd11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2546827195","title":"宜明昂科-B盘中异动 早盘股价大跌5.11%报12.640港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546827195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546827195?lang=zh_cn&edition=full","pubTime":"2025-06-26 11:02","pubTimestamp":1750906952,"startTime":"0","endTime":"0","summary":"2025年06月26日早盘11时02分，宜明昂科-B股票出现波动，股价大幅下挫5.11%。截至发稿，该股报12.640港元/股，成交量226.19万股，换手率0.57%，振幅9.76%。资金方面，该股资金流入769.295万港元，流出1788.41万港元。宜明昂科-B股票所在的生物技术行业中，整体跌幅为1.35%。其相关个股中，正大企业国际、华康生物医学、同源康医药-B涨幅较大，振幅较大的相关个股有北海康成-B、正大企业国际、同源康医药-B，振幅分别为24.18%、15.79%、11.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110232a71e11b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110232a71e11b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2545006874","title":"宜明昂科-B06月24日主力净流入167.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545006874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545006874?lang=zh_cn&edition=full","pubTime":"2025-06-24 16:15","pubTimestamp":1750752928,"startTime":"0","endTime":"0","summary":"06月24日, 宜明昂科-B股价涨2.56%，报收12.80元，成交金额5232.5万元，换手率1.01%，振幅8.33%，量比1.19。宜明昂科-B今日主力资金净流入167.1万元，上一交易日主力净流出112.3万元。该股近5个交易日上涨2.73%，主力资金累计净流出250.2万元；近20日主力资金累计净流出232.6万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624172449a71af3ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624172449a71af3ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2545457134","title":"宜明昂科-B盘中异动 股价大跌5.24%报11.940港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545457134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545457134?lang=zh_cn&edition=full","pubTime":"2025-06-23 09:32","pubTimestamp":1750642367,"startTime":"0","endTime":"0","summary":"2025年06月23日早盘09时32分，宜明昂科-B股票出现异动，股价大幅下挫5.24%。截至发稿，该股报11.940港元/股，成交量7.72万股，换手率0.02%，振幅5.40%。资金方面，该股资金流入45.6488万港元，流出41.028万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，药捷安康-B、和铂医药-B、正大企业国际涨幅较大，振幅较大的相关个股有北海康成-B、药捷安康-B、宜明昂科-B，振幅分别为12.12%、9.89%、5.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093247a717d531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093247a717d531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2545561824","title":"宜明昂科-B：IMC-003/IMM72获国家药监局批准进行临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2545561824","media":"格隆汇资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545561824?lang=zh_cn&edition=full","pubTime":"2025-06-23 06:34","pubTimestamp":1750631667,"startTime":"0","endTime":"0","summary":"格隆汇6月23日丨宜明昂科-B(01541.HK)发布公告，集团获得中国国家药品监督管理局(“国家药监局”)有关启动IMC-003/IMM72治疗肺动脉高压(PAH)的临床试验的新药临床试验(IND)批准。IMC-003/IMM72为通过基因改造的新一代启动素受体IIA-Fc型(ActRIIA-Fc)融合蛋白，具有更高的活性及品质。集团拥有IMC-003/IMM72的全球知识产权以及开发及商业化权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623063433978a577b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623063433978a577b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01541","03347","BK1141","BK1576"],"gpt_icon":0},{"id":"2544978638","title":"宜明昂科-B06月18日主力净流入162.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2544978638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544978638?lang=zh_cn&edition=full","pubTime":"2025-06-18 16:15","pubTimestamp":1750234525,"startTime":"0","endTime":"0","summary":"06月18日, 宜明昂科-B股价涨0.48%，报收12.52元，成交金额5053.0万元，换手率1.04%，振幅4.49%，量比0.74。宜明昂科-B今日主力资金净流入162.6万元，上一交易日主力净流出570.6万元。该股近5个交易日下跌12.01%，主力资金累计净流出789.5万元；近20日主力资金累计净流入3533.4万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618173048a4b04090&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618173048a4b04090&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2543606630","title":"宜明昂科-B(01541)：赎回及认购理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543606630?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:40","pubTimestamp":1750084848,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，公司已于2025年6月16日通知海通资产管理，以现金赎回2亿港元的海通产品，即其当时持有的全部海通产品，估计收益约为510.2万港元(即赎回事项产生的未经审计利息收入)。于赎回事项后，集团将不再持有海通资产管理任何尚未到期理财产品。此外，于2025年6月16日，公司同意向申万宏源证券(香港)认购金额为2.05亿港元的理财产品(申万产品)。认购事项由集团的内部盈余现金储备提供资金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2543678313","title":"宜明昂科-B06月16日主力净流入216.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2543678313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543678313?lang=zh_cn&edition=full","pubTime":"2025-06-16 16:15","pubTimestamp":1750061751,"startTime":"0","endTime":"0","summary":"06月16日, 宜明昂科-B股价涨1.96%，报收13.50元，成交金额3792.0万元，换手率0.72%，振幅6.95%，量比0.37。宜明昂科-B今日主力资金净流入216.1万元，上一交易日主力净流出652.6万元。该股近5个交易日下跌5.30%，主力资金累计净流出1230.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入4823.6万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616173911a70bc6cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616173911a70bc6cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0}],"profile":{"websiteUrl":"http://immuneonco.com","stockEarnings":[{"period":"1week","weight":-0.1364},{"period":"1month","weight":-0.2447},{"period":"3month","weight":0.9802},{"period":"6month","weight":1.0619},{"period":"1year","weight":-0.2163},{"period":"ytd","weight":0.938}],"compareEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.1678},{"period":"6month","weight":0.2596},{"period":"1year","weight":0.3649},{"period":"ytd","weight":0.2258}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜明昂科生物医药技术（上海）股份有限公司是一家主要从事开发肿瘤免疫疗法的中国公司。该公司的主要业务包括开发用于系统利用先天性和适应性免疫的生物技术，以及开发下一代肿瘤免疫疗法，免疫疗法主要专注于适应性免疫系统。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"宜明昂科-B","nameEN":"IMMUNEONCO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宜明昂科-B(01541)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宜明昂科-B,01541,宜明昂科-B股票,宜明昂科-B股票老虎,宜明昂科-B股票老虎国际,宜明昂科-B行情,宜明昂科-B股票行情,宜明昂科-B股价,宜明昂科-B股市,宜明昂科-B股票价格,宜明昂科-B股票交易,宜明昂科-B股票购买,宜明昂科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宜明昂科-B(01541)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}